top of page
  • Writer's pictureA2A Pharma

A2A Finalist

Updated: Feb 7, 2020

A2A was a finalist at RESI NYC tech hub pitch challenge


44 views0 comments

Recent Posts

See All

Biomea Fusion, Inc., a precision oncology company dedicated to developing innovative medicines targeting genomically defined alterations in both hematologic and solid cancers, announced the closing of

bottom of page